Brain Sleep Clearance of Amyloid-Beta Peptides

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

July 31, 2019

Conditions
Obstructive Sleep ApneaAlzheimer's Disease
Interventions
OTHER

Continuous positive airway pressure device

GROUP B ONLY will be evaluated on two randomized counterbalanced nights, on one they will undergo a full night of therapeutic CPAP; on the other the investigators will withdraw CPAP during SWS only. A morning LP will be performed approximately 10 hours after sleep onset in both visits

Trial Locations (2)

10016

Bellevue Hospital Center, New York

NYU Langone Medical Center, New York

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

NYU Langone Health

OTHER

NCT02474251 - Brain Sleep Clearance of Amyloid-Beta Peptides | Biotech Hunter | Biotech Hunter